<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(40)</volume><submitter>Han H</submitter><pubmed_abstract>Hepatocellular carcinoma (HCC) is a common malignant tumor. However, the role of lactic acid-modified proteins in its pathogenesis is unclear. This study determines the distribution of a novel post-translational modification-protein lactylation-in HCC to identify potential targets and obtain mechanistic insights into this disease. Using high-throughput proteomics, lysine 312 lactylation (K312-lac) of the Set1/Ash2 histone methyltransferase complex subunit (ASH2L) is revealed as a candidate for further investigation. Subsequently, alanyl-tRNA synthetase 1 (AARS1) and histone deacetylase 1 (HDAC1) are shown to mediate lactylation modification of ASH2L. In vivo experiments demonstrate that ASH2L-K312-lac promotes HCC malignant progression and is positively correlated with tumor microvessel de</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pagination>e09477</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12561209</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ASH2L-K312-Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant Progression of Hepatocellular Carcinoma.</pubmed_title><pmcid>PMC12561209</pmcid><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Gu X</pubmed_authors><pubmed_authors>Xia S</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors><pubmed_authors>Yin H</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Han H</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Zhao D</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhu R</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>ASH2L-K312-Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant Progression of Hepatocellular Carcinoma.</name><description>Hepatocellular carcinoma (HCC) is a common malignant tumor. However, the role of lactic acid-modified proteins in its pathogenesis is unclear. This study determines the distribution of a novel post-translational modification-protein lactylation-in HCC to identify potential targets and obtain mechanistic insights into this disease. Using high-throughput proteomics, lysine 312 lactylation (K312-lac) of the Set1/Ash2 histone methyltransferase complex subunit (ASH2L) is revealed as a candidate for further investigation. Subsequently, alanyl-tRNA synthetase 1 (AARS1) and histone deacetylase 1 (HDAC1) are shown to mediate lactylation modification of ASH2L. In vivo experiments demonstrate that ASH2L-K312-lac promotes HCC malignant progression and is positively correlated with tumor microvessel de</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T09:29:51.618Z</modification><creation>2026-05-15T03:12:17.113Z</creation></dates><accession>S-EPMC12561209</accession><cross_references><pubmed>40726441</pubmed><doi>10.1002/advs.202509477</doi></cross_references></HashMap>